Improving how we understand Alzheimer's and similar brain diseases
Statistical Methods for Integrating Mixed-type Biomarkers and Phenotypes in Neurodegenerative Disease Modeling
['FUNDING_R01'] · COLUMBIA UNIVERSITY HEALTH SCIENCES · NIH-11004368
This project aims to create better ways to use different types of patient information to understand and treat Alzheimer's disease and other brain conditions.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLUMBIA UNIVERSITY HEALTH SCIENCES (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11004368 on ClinicalTrials.gov |
What this research studies
Many brain disorders, like Alzheimer's, are hard to diagnose early and progress slowly, making treatments difficult to develop. This project focuses on creating advanced computer methods to combine various patient data, such as traditional medical tests and new "digital biomarkers" from everyday activities. By bringing together information from large groups of patients, we hope to get a clearer picture of how these diseases affect individuals. This approach could lead to more personalized ways to predict, diagnose, and treat these complex conditions.
Who could benefit from this research
Good fit: This research is relevant to patients with Alzheimer's disease and other neurodegenerative conditions, as it uses their data to develop new analytical tools.
Not a fit: Patients not affected by neurodegenerative diseases would not directly benefit from the outcomes of this specific research.
Why it matters
Potential benefit: If successful, this work could lead to more accurate diagnoses, better predictions of disease progression, and more personalized treatment strategies for neurodegenerative diseases.
How similar studies have performed: While the integration of diverse data types and advanced analytical methods is an evolving field, similar approaches in data science have shown promise in other areas of medicine.
Where this research is happening
NEW YORK, UNITED STATES
- COLUMBIA UNIVERSITY HEALTH SCIENCES — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WANG, YUANJIA — COLUMBIA UNIVERSITY HEALTH SCIENCES
- Study coordinator: WANG, YUANJIA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease